MedPath

Change of Retinally-Induced Aniseikonia in Patients With Epiretinal Membrane After Vitrectomy

Completed
Conditions
Epiretinal Membranectomy
Registration Number
NCT01901406
Lead Sponsor
Yonsei University
Brief Summary

Epiretinal membrane is common disease, affecting 5\~10 % incidence over 60 years old population. It reduce visual acuity, cause metamorphopsia. In the past, vitrectomy and epiretinal membranectomy was indicated in patients with visual acuity less than 20/40, but nowadays with technical improvement and surgical instrument renovation, it seems to have been changed the surgical indication. Therefore, we plan to evaluate the changes of binocular visual acuity, aniseikonia in patients with epiretinal membrane.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Idiopathic epiretinal membrane who had impaired vision or metamorphopsia, want to undergo vitrectomy
  • Age more than 20 years and less than 90 years old
Read More
Exclusion Criteria
  • secondary epiretinal membrane due to retinal surgery,
  • impaired visual acuity less than 20/40 in the normal eye(Snellen chart) due to severe cataract
  • glaucoma patients
  • complication during vitrectomy (ex. Retinal tear, silicone oil injection, ...)
  • other retinal disease except epiretinal membrane
  • other ocular surgery history within 3 months
  • intellectual problems or illiterate whom could not obtained informed consent
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Titmus test (arc of second)from Initial screening day before surgey to postoperative 6 months
Changes of Stereopsis tested by TNO test (arc of second)from Initial screening day before surgey to postoperative 6 months

Stereopsis is normal binocular vision. Its presence or absence is an important indicator of the state of binocularity. The TNO test is graded to provide retinal disparities ranging from 15 to 480 second of arc.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institute of Vision Research, Department of Ophthalmology, Gangnam Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath